Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Policy uncertainty and prolonged interest rate stagnation loom over the market like storm clouds and investors are finding ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The single largest veto affects the Group Insurance Commission, where Healey made a $27.5 million reduction (out of $2.37 ...

When choosing a refreshing drink, why not opt for one that not only hydrates but also helps you slim thanks to the power of ...

More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...

The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.

Kate Farms has launched high-protein plant-based shakes to tackle "critical nutrition gaps" from GLP-1 use, its first product ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Benefit managers will need to modernize their strategies and offerings around well-being, caregiving and professional ...

Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that it will host an investor event at the Endocrine Society’s annual meeting (ENDO 2025) on Sunday, July 13, ...